Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice - PubMed (original) (raw)
Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice
S H Gavett et al. Am J Physiol. 1997 Feb.
Abstract
The functional role of interleukin (IL)-4 in the development of airway hyperresponsiveness (AHR) and pulmonary eosinophilia in response to sensitization and challenge of mice with sheep red blood cells (SRBC) was examined. Control- and SRBC-sensitized A/J mice were treated with an antibody to the murine IL-4 receptor (anti-IL-4R) 3 days before intratracheal challenge with the antigen or vehicle only. Blockade of IL-4R significantly reduced antigen-induced AHR and prevented increases in goblet cells and bronchoalveolar lavage (BAL) eosinophils. Treatment with anti-IL-4R did not affect antigen-induced increases in lung mRNA and BAL protein levels of IL-5 and interferon-gamma or IL-4 mRNA but did significantly increase IL-4 protein levels. Antigen-induced AHR was not reduced by treatment with antibodies to the adhesion molecules, vascular cell adhesion molecule-1 and very late activation antigen-4. Administration of IL-4 over a 7-day period did not increase airway reactivity or induce any changes in BAL cell numbers in naive mice. These results demonstrate that IL-4 is necessary for in vivo development of antigen-induced AHR, goblet cell metaplasia, and pulmonary eosinophilia.
Similar articles
- Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.
Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Gavett SH, et al. J Exp Med. 1995 Nov 1;182(5):1527-36. doi: 10.1084/jem.182.5.1527. J Exp Med. 1995. PMID: 7595222 Free PMC article. - Role of very late activation antigen-4 in the antigen-induced accumulation of eosinophils and lymphocytes in the lungs and airway lumen of sensitized brown Norway rats.
Richards IM, Kolbasa KP, Hatfield CA, Winterrowd GE, Vonderfecht SL, Fidler SF, Griffin RL, Brashler JR, Krzesicki RF, Sly LM, Ready KA, Staite ND, Chin JE. Richards IM, et al. Am J Respir Cell Mol Biol. 1996 Aug;15(2):172-83. doi: 10.1165/ajrcmb.15.2.8703473. Am J Respir Cell Mol Biol. 1996. PMID: 8703473 - Antibody to very late activation antigen 4 prevents interleukin-5-induced airway hyperresponsiveness and eosinophil infiltration in the airways of guinea pigs.
Kraneveld AD, van Ark I, Van Der Linde HJ, Fattah D, Nijkamp FP, Van Oosterhout AJ. Kraneveld AD, et al. J Allergy Clin Immunol. 1997 Aug;100(2):242-50. doi: 10.1016/s0091-6749(97)70231-8. J Allergy Clin Immunol. 1997. PMID: 9275147 - Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases.
Nasert S, Millner M, Herz U, Lack G, Wahn U, Gelfand EW, Renz H. Nasert S, et al. Behring Inst Mitt. 1995 Jun;(96):118-30. Behring Inst Mitt. 1995. PMID: 7575347 Review. - Immunosuppression by blocking alpha 4-integrins/VCAM-1 adhesion.
Isobe M, Hori J, Suzuki J. Isobe M, et al. Curr Top Microbiol Immunol. 1998;231:85-98. doi: 10.1007/978-3-642-71987-5_6. Curr Top Microbiol Immunol. 1998. PMID: 9479862 Review. No abstract available.
Cited by
- Inhibition of MAPK and STAT3-SOCS3 by Sakuranetin Attenuated Chronic Allergic Airway Inflammation in Mice.
Santana FPR, da Silva RC, Grecco SDS, Pinheiro AJMCR, Caperuto LC, Arantes-Costa FM, Claudio SR, Yoshizaki K, Macchione M, Ribeiro DA, Tibério IFLC, Lima-Neto LG, Lago JHG, Prado CM. Santana FPR, et al. Mediators Inflamm. 2019 Sep 3;2019:1356356. doi: 10.1155/2019/1356356. eCollection 2019. Mediators Inflamm. 2019. PMID: 31565031 Free PMC article. - IL-4 and IL-13 Receptor Signaling From 4PS to Insulin Receptor Substrate 2: There and Back Again, a Historical View.
Keegan AD, Zamorano J, Keselman A, Heller NM. Keegan AD, et al. Front Immunol. 2018 May 15;9:1037. doi: 10.3389/fimmu.2018.01037. eCollection 2018. Front Immunol. 2018. PMID: 29868002 Free PMC article. Review. - NKT cells contribute to basal IL-4 production but are not required to induce experimental asthma.
McKnight CG, Morris SC, Perkins C, Zhu Z, Hildeman DA, Bendelac A, Finkelman FD. McKnight CG, et al. PLoS One. 2017 Nov 28;12(11):e0188221. doi: 10.1371/journal.pone.0188221. eCollection 2017. PLoS One. 2017. PMID: 29182669 Free PMC article. - Interleukin-4 receptor alpha is still required after Th2 polarization for the maintenance and the recall of protective immunity to Nematode infection.
Nono JK, Ndlovu H, Abdel Aziz N, Mpotje T, Hlaka L, Brombacher F. Nono JK, et al. PLoS Negl Trop Dis. 2017 Jun 26;11(6):e0005675. doi: 10.1371/journal.pntd.0005675. eCollection 2017 Jun. PLoS Negl Trop Dis. 2017. PMID: 28651009 Free PMC article. - Long-Acting Beta Agonists Enhance Allergic Airway Disease.
Knight JM, Mak G, Shaw J, Porter P, McDermott C, Roberts L, You R, Yuan X, Millien VO, Qian Y, Song LZ, Frazier V, Kim C, Kim JJ, Bond RA, Milner JD, Zhang Y, Mandal PK, Luong A, Kheradmand F, McMurray JS, Corry DB. Knight JM, et al. PLoS One. 2015 Nov 25;10(11):e0142212. doi: 10.1371/journal.pone.0142212. eCollection 2015. PLoS One. 2015. PMID: 26605551 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases